Utility of MIB-1 and estrogen and progesterone receptor in distinguishing between endometrial stromal sarcomas and endometrial stromal nodules, highly cellular leiomyomas
- 1 March 2005
- journal article
- research article
- Published by Elsevier in International Journal of Gynecologic Cancer
- Vol. 15 (2) , 337-342
- https://doi.org/10.1111/j.1525-1438.2005.15226.x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Low-grade endometrial stromal sarcoma: hormonal aspects☆Gynecologic Oncology, 2003
- Endometrial Stromal Nodules and Endometrial Stromal Tumors With Limited InfiltrationThe American Journal of Surgical Pathology, 2002
- An Immunohistochemical Analysis of Endometrial Stromal and Smooth Muscle Tumors of the gUterusThe American Journal of Surgical Pathology, 2002
- Utility of CD10 in Distinguishing between Endometrial Stromal Sarcoma and Uterine Smooth Muscle Tumors: An Immunohistochemical Comparison of 34 CasesLaboratory Investigation, 2001
- Immunohistochemical Profile of Endometrial Adenocarcinoma: A Study of 61 Cases and Review of the LiteratureLaboratory Investigation, 2000
- Prognostic Significance of Progesterone Receptor Immunohistochemistry in Endometrial CarcinomaGynecologic Oncology, 1998
- A Comparative Morphologic and Immunohistochemical Analysis of 33 Highly Cellular Leiomyomas and Six Endometrial Stromal Nodules, Two Frequently Confused TumorsThe American Journal of Surgical Pathology, 1995
- Leiomyosarcoma Versus Bizarre and Cellular Leiomyomas of the UterusInternational Journal of Gynecological Pathology, 1995
- An Immunohistochemical Study of Normal Endometrial Stroma and Endometrial Stromal NeoplasmsThe American Journal of Surgical Pathology, 1991
- Primary Uterine Endometrial Stromal NeoplasmsThe American Journal of Surgical Pathology, 1990